.png)
Agenzia Italiana del Farmaco
home
Highlights
-
09 Oct 2025
Press releases
Medicines approved for reimbursement by the AIFA Board of Directors. These include two new molecules, three generics, three biosimilars and an extension of therapeutic indication
Green light for the reimbursement of the first subcutaneous treatment for paroxysmal nocturnal haemoglobinuria and the first three biosimilars of denosumab, the monoclonal antibody indicated for osteoporosis and bone loss.
-
23 Sep 2025
Press releases
Use of paracetamol during pregnancy: European recommendations confirmed
The Italian Medicines Agency (AIFA) reports that, in light of the latest scientific assessments carried out at European level, there is no new evidence requiring changes to the current recommendations.
-
22 Sep 2025
Press releases
AIFA monitoring of pharmaceutical expenditure January-April 2025
Spending on medicines purchased directly by the Regions slows down.
-
18 Sep 2025
Press releases
The NHS will reimburse the first gene editing therapy for β-thalassemia and sickle cell anaemia
The AIFA Board of Directors approves the reimbursement of 7 new medicinal products (including 2 orphans), 6 generic medicines and 6 extensions of therapeutic indications.
News
12 Sep 2025
Press releases
“Medicines are not sweets”. A European campaign to promote the responsible use of over-the-counter medicines
10 Sep 2025
Press releases
AIFA launches the second Independent Research Call for year 2025
03 Sep 2025
The Agency
Telephone switchboard service and FarmaciLine toll-free number (update)
09 Oct 2025
Safety of medicinal products
Direct Healthcare Professional Communication (DHPC) on Crysvita (burosumab)
09 Oct 2025
Safety of medicinal products
Direct Healthcare Professional Communication (DHPC) on Caspofungin
03 Oct 2025
Monitoring Registers
Hepatitis C: update of 29 September 2025 concerning enrolled patients
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
Media
